How did LIVN's Q4 2024 earnings surprise impact investor sentiment?

**LivaNova's Q4 2024 earnings surprise had a positive impact on investor sentiment**, as evidenced by several key indicators:

1. **Earnings Surprise**: LivaNova reported an EPS surprise of $0.01 for Q4 2024. This positive surprise indicates that the company's performance exceeded market expectations, which typically leads to increased investor confidence.

2. **Stock Price Reaction**: Following the earnings release, LivaNova's stock price increased by 5.52%. This significant uptick reflects investor optimism about the company's future prospects.
3. **Analyst Optimism**: Analysts have been optimistic about LivaNova's future, with revenue growth forecasts averaging 4.4% per annum over the next three years, compared to the industry average of 8.2%. This suggests that analysts believe LivaNova's performance will continue to improve, which can boost investor sentiment.
4. **Sector Performance**: LivaNova's performance within the Medical Equipment industry is strong, with a 15% revenue increase in the Cardiopulmonary segment and 8.5% growth in the Neuromodulation segment. This sector performance can contribute to overall market confidence in the company.
5. **Guidance Update**: LivaNova has raised its full-year 2024 guidance, indicating a positive outlook on future performance. This guidance update can enhance investor confidence, as it suggests that the company is optimistic about its ability to grow and meet financial targets.

In conclusion, LivaNova's Q4 2024 earnings surprise, along with the company's strong sector performance and optimistic guidance, have likely contributed to a positive sentiment among investors.